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ABSTRACT
ROLE OF MITOGEN ACTIVATED KINASES IN CD40-MEDIATED T CELL
ACTIVATION OF MONOCYTE/MACROPHAGE AND VASCULAR SMOOTH
MUSCLE CELL CYTOKINE/CHEMOKINE PRODUCTION
by
Denise M. Milhom

Atherogenesis is characterized by the infiltration of immune competent cells such as
monocytes/macrophages and T cells to the site of lesion formation, resembling a
chronic inflammatory response. Histological studies have shown the T cells present at
these lesions are activated, CD 154^, CD4^ T cells of the T hl or inflammatory
phenotype. The presence of these cells may be critical in regulating vascular
inflammation due to their capacity to activate proinflammatory activities in CD40^ cells
in the vasculature including monocytes/macrophages and vascular smooth muscle cells
(SMC), through the CD40:CD1S4 receptor ligand interaction. This dissertation
represents efforts to determine the functional consequences acquired by SMC in
response to CD40 ligation by activated CD 154^ T cells, and to elucidate components of
the signaling pathway(s) activated in response to CD40 signaling in both monocytes and
SMC.
To study the consequences of CD40 stimulation, primary human monocytes and aortic
SMC were treated with plasma membranes purified from CD 154*, CD4* T cells. The
ability of CD40 signaling to initiate cytokine/chemokine mRNA and protein synthesis
was assayed by RNAse protection assay, and enzyme linked immuosorbent assay
(ELISA), respectively. Western blot analysis was used to determine the activation state
of members of the mitogen activated protein kinase (MAPK) family following CD40
stimulation. In addition, the activation of the transcription factor, NFkB, which has
been demonstrated to contribute the the induction of cytokine/chemokine expression
was analyzed by electromobility shift assay (EMSA). Analysis of SMC cell surface
expression of receptors responsive to T cell ligands, and the analysis of CD40-mediated
regulation of SMC adhesion and co-stimulatory molecules was analyzed by flow
cytometry.
The results presented in this dissertation demonstrate that SMC, like
monocytes/macrophages, are capable of interacting with T cells in a manner that results
in reciprocal activation events. SMC were shown to present antigen to, and activate T
iii
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cells. In turn T cell stimulus resulted in the activation of proinflammatory function in
SMC initiated through the CD154:CD40 interaction. CD40 stimulation of SMC
resulted in the production of the chemokines interleukin 8 (EL-8) and macrophage
chemotactic protein-1 (MCP-1), and the upregulation of intercellular adhesion molecule
(ICAM). Examination of the intracellular signaling pathways activated through CD40
signaling revealed the involvement of MAPKs in the pathway leading to induction of
proinflammatory activity. Evaluation of CD40 signaling in monocytes demonstrated
the activation of the MAPK flunily members ERKl/2, but not the MAPK family
members p38 or c-jun-N-terminal kinase (INK). In contrast, CD40 signaling in SMC
was shown to result in ERKl/2 and p38 activation, and both of these kinases were
shown to play a critical role in the induction of chemokine synthesis. An examination
of the ability of anti-inflammatory (tytokines to modulate CD40 signaling in monocytes
and SMC demonstrated that the anti-inflammatory cytokines IL-4 and IL-10 abrogate
CD40-mediated induction of inflammatory cytokine production by monocytes. This
inhibition was shown to be a result of a negative influence of IL-4 and IL-10 on CD40
mediated ERKl/2 activation in monocytes. However, IL-4 and IL-10 did not inhibit
SMC proinflammatory responses indicating a difference in the intracellular responses to
these cytokines by the two cell types.
These studies contribute to the understanding of the interaction between SMC and
CD4* T cells through the receptor:ligand pair CD40:CD154, and its role in the
maintenance of vascular inflammation The identification of the signaling components
of the monocyte and SMC CD40 signaling pathways will identify control points that
may serve as targets for anti-inflammatory therapies.

IV
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CHAPTER 1
INTRODUCTION

Cell Interactions and the Role of Cvtoldnes and Chemokines in Atherosclerosis
Atherogenesis is characterized by the infiltration of immune competent cells, such
as monocytes/macrophages and T lymphocytes at the site of a vascular lesion
resembling a chronic inflammatory response. Tissue sections of atherosclerotic plaques
have revealed that the T lymphocytes at the site of the vascular lesion are activated,
CD 154*, CD4*T helper cells of the Thl or inflammatory phenotype (Mach and others
1998). These activated T cells may interact with cells in the vasculature through the
receptor-ligand interaction of CD 154, expressed on activated T cells with its receptor
CD40 expressed on a diverse group of cells including smooth muscle cells and
monocytes/macrophages (Figure 1). This interaction has been shown to result in the up
regulation of costimulatory and adhesion molecule expression, and the induction of
inflammatory cytokine and chemokine synthesis in monocytes, and may result in similar
functional consequences in SMC. We hypothesize that the interaction between
activated T cells and monocytes, and activated T cells and SMC through the receptorligand pair CD40:CD154 results in inflammatory cytokine and chemokine synthesis
contributing to the pathogenesis of atherosclerosis.
The presence of activated CD4* T cells at atherosclerotic lesions has been well
established (Mach and others 1998). However the role of T cells in the maintenance
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Figure 1. Overview of CeilrCeil Interactions Occurring in Vascular Inflammation. A
cross-sectional view of an artery illustrating cellzcell interactions which may be
occurring through the receptor-ligand pair CD40:CD154 during atherogenesis.
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and/or exacerbation of atherosclerosis has not been elucidated. Research thus far has
indicated that T cells appear early in the onset of atherosclerosis and localize to the site
of insult or injury to the artery. T cells transmigrate through the endothelium from the
media to the intima of the aorta where they have the ability to interact with many cells
in the vasculature through the receptor-ligand pair CD1S4:CD40. Recently there has
been increasing amounts of evidence that support a critical role of T cells in regulating
vascular inflammation or atherosclerosis (Mach and others 1998). Treatment with
antibodies against murine CD 154 limits atherosclerosis in susceptible mice, and the
atheroma of mice treated with anti-CD 154 antibodies contains significantly fewer
immune competent cells suggesting the involvement of inflammatory pathways and a
role for CD40 signaling in atherosclerosis (Mach and others 1998). Additionally, T
cells have the capacity to produce growth frctors such as basic fibroblast growth factor
(bFGF) and heparin binding epidermal growth factor (HB-EGF) which are potent
mitogens for SMC proliferation (Rolfe and others 1995), and several cytokines
including IFNy, a known co-stimulus for macrophage activation, which enhances
macrophage efrector function and induces or enhances MHC class H expression by
many cells including macrophages, endothelial cells and SMC.
Smooth muscle cells and monocytes/macrophages are thought to play a crucial role
in the process of atherogenesis. Both monocytes/macrophages and SMC have the
propensity to become lipid-laden foam cells which contribute to the formation of the
atherosclerotic plaque. Additionally, monocytes/macrophages and SMC may amplify
the inflammatory process resulting in atherosclerosis due to their ability to express
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class n histoconqiatibility (MHC class ü) (Warner and Libby 1989). Class H
expression in atherosclerotic lesions in vivo has been well documented (Hansson and
others 1986) suggesting that antigen presentation may be occurring at atherosclerotic
lesions resulting in the activation of T cells. Antigens present in atherosclerotic plaques
may include modified lipoproteins, neoantigens revealed through tissue destruction and
determinants arising from infectious agents (Libby and Hansson 1991). Furthermore,
monocytes/macrophages and SMC have been shown to express CD40 which can
interact with CD 154 present on activated T cells. Recent research has shown that
ligation of CD40 on atheroma-associated cells (i.e. monocytes/macrophages and SMC)
in vitro activates fimctional attributes such as the production of cytokines, chemokines,
and adhesion molecules which are some of the critical components required for the
directional migration of leukocytes during inflammatory processes. The inflammatory
cytokines, tumor necrosis factor (TNF) a and IL-1 p are both know to be involved in
inflammatory diseases and are produced by several cell types including
monocytes/macrophages and SMC. Interleukin (IL)-8 and monocyte chemotactic
protein-1 (MCP-1) are well characterized members of the C-X-C and C-C chemokine
subfamilies, respectively (Beasley and others 1995), are pro-inflammatory in nature,
and are produced by several cell types including vascular smooth muscle cells and
monocytes/macrophages. Histological studies have demonstrated these inflammatory
cytokines and chemokines to be present in atherosclerotic plaques, suggesting that they
may play a crucial role in the development, maintenance, and pathogenesis of
atherogenesis by promoting the directed migration of inflammatory cells (Warner and
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Libby 1989; Wang and others 1998; Liu and others 1997; Terkeltaub and others 1998).
MCP-1 mRNA has been detected in several cells including macrophages, endothelial
cells and SMCs in atherosclerotic arteries of patients undergoing a bypass
revascularization (Seino and others 1995). Recent reports have shown that mice
deficient in MCP-1 that were fed a high cholesterol diet deposited less lipids and had
fewer macrophages present within their aortic walls as compared to the wildtype control
(Boring and others 1998). Similarly, mice deficient in the MCP-1 receptor, CCR-2,
had a overall decrease in atherosclerotic lesion size, and had significantly fewer
macrophages and monocytes present in the aortas as compared to the wildtype control
(Gu and others 1998). IL-8 is chemotactic for several cell types including T cells and
neutrophils at picomolar and nanomolar concentrations respectively (Banka and others
1991), and may be involved in the recruitment of T cells to the intima of a blood vessel
contributing to the pathogenesis of atherosclerosis (Larsen and others 1989).

Structure and Function of CD40
CD40 is a transmembrane glycoprotein of approximately 45kDa, a member of the
tumor necrosis receptor superfamily, which also includes the TNF receptor (TNFRl
and TNFR2), nerve growth factor receptor, and Fas (CD95). CD40 is expressed by a
variety of cell types including B cells (Clark 1990), monocytes/macrophages (Alderson
and others 1993), dendritic cells (Caux and others 1994), thymic epithelial cells (Galy
and Spits 1992), endothelial cells (Yellin and others 1995), kératinocytes (PeguetNavarro and others 1996), and smooth muscle cells (Mach and others 1998). CD40
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interacts with its ligand, CD 154, a type H membrane protein o f approximately 39 kDa,
and a member of the TNF superfamily. CD 154 is preferentially expressed on
activated, but not resting T cells (Lynch and Ceredig 1989; Nbelle and Snow 1992).
Engagement of CD40 by its ligand CD154 has been reported to induce functional
changes on these cell types that may contribute to inflammatory responses, including
the secretion of pro-inflammatory (tytokines and chemokines, the up-regulation of
costimulatory and adhesion molecules (Stout and Suttles 1996), and eflects on cellular
proliferation (Yellin and others 1995). CD40 and its receptor CD 154 has been
identified as a receptor:ligand pair which œntributes to contact dependent signaling
between monocytes and T cells. The importance of CD 154 in vivo was revealed by
studies of X-linked Hyper-IgM Syndrome patients,. Hyper-IgM Syndrome is an
immuncxleficiency characterized by the absence of circulating IgA and IgG and the
absence of germinal centers, which is a result of defects in the gene encxxling CD 154
(Klein and Miedema 1995). CD40 was initially identified on the surface of B cells
Banchereau and others 1994) where CD40 signaling provides critical costimulatory
signals required for proliferation, isotype switching, germinal center formation, and the
generation of memory B cells (Grabstein and others 1993). The signaling pathways
activated through CD40 in B cælls involve activation of the src family PTK’s, PKC,
Jak3, serine/theonine kinases, MAPK family members (JNK, p38 and ERKl/2) and
PLCy2 (Aagaard-Tillery and Jelinek 1996; Padmore and others 1997; Hanissian and
Geha 1997).
In monocytes/macrophages, CD40 ligation has been shown to induce monocyte-

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

derived inflammatory cytokine synthesis (Wagner and others 1994), nitric oxide
production (Stout and others 1996), and to rescue monocytes from undergoing
apoptosis (programmed cell death) induced by the deprivation of serum factors (Suttles
and others 1996). Additionally, our laboratory has demonstrated that CD40-mediated
rescue from apoptosis is critically dependent on the activation of PTK but does not
appear to involve the serine/threonine kinase PKC family (Suttles and others 1996).
Our laboratory has also observed activation of the transcription factor Nuclear Factorkappa B (NF-kB) in response to CD40 signaling in monocytes. NF-kB is a
transcription frctor involved in the transcription of several genes. It is present in the
cytosol in an inactive state, complexed with the inhibitory I kappa B (IkB) proteins
(Baeuerle and Baltimore 1988; Beg and others 1993; Finco and others 1994).
Activation of NF-kB occurs through phosphorylation of iKB-a at serine 32 and 36,
resulting in the release and nuclear translocation of active NF-kB where it can bind
relevant gene promotors (Brown and others 1995; Brockman and others 1995; Chen
and others 1996). The release of active NF-kB results from the phosphorylated IkB
conjugating with ubiquitin followed by proteaosome-mediated degradation of IkB (Chen
and others 1996).
CD40 does not contain cytoplasmic sequences with catalytic activity and has been
shown to signal through cytoplasmic adaptor proteins of the TNF receptor-associated
factor family (TRAF), which activate intracellular signaling pathways (Dadgostar and
Cheng 1998). All TRAF family members contain homologous C-terminal TRAF
domains, TRAFs 2 through 6 contain an N-terminal ring finger and zinc finger-like
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domains (Dadgostar and Cheng 1998), and TRAF 3 and TRAF 5 contain an isoleucine
zipper domain (Cheng and others 1995; Ishida and others 1996; Nakano and others
1996). TRAFs 2, 5 and 6 interaction with CD40 has been associated with activation of
the transcription frctor NF-kB (Ishida and others 1996), however the disruption of
CD40 cytoplasmic sequences involved in TRAF interaction does not eliminate
NF-kB activation (Using and others 1997). Additionally, signalmg through CD40 can
initiate TRAF mediated activation of MAPK family members (Natoli and others 1997),
however the role of the TRAF family members in CD40-mediated activation of
monocytes/macrophages and SMCs has not been investigated.
Previous research in our laboratory has demonstrated modulation of CD40-mediated
monocyte inflammatory cytokine synthesis by the Th2-derived anti-inflammatory
cytokines IL-4 and IL-10 (Poe and others 1998). Several studies have shown inhibition
of monocyte/macrophage inflammatory function in response to lipopolysaccharride
(LPS) (Moore and others 1993). In vivo, it has been shown that these cytokines reduce
autoimmune inflammatory diseases, and IL-10 is being used in clinical trials to treat
autoimmune diseases (Horsfall and others 1997; Narula and others 1998). The
mechanism by which IL-4 and IL-10 inhibit inflammatory cytokine synthesis has not
been elucidated, however previous research in our laboratory suggested that the
effectiveness of these cytokines may result from the inhibition of the signaling
pathway(s) activated in response to CD40 ligation in monocytes. Our laboratory has
recently shown that IL-4 and IL-10 act early in the CD40 signaling cascade by
modulating the overall PTK induction in monocytes.
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Both IL-4 and IL-10 signal through receptors which associate with and activate the
Janus family (Jak) tyrosine kinases upon ligation (O’Shea 1997; Leonard and O’Shea
1998). The Jaks in turn, activate proteins called Signal Transducers and Activators of
Transcription (Stats). The Stats translocate to the nucleus where they regulate the
expression of various genes (Darnell 1997) (Figure 2). The Stats are inducers of a
family of negative regulators of (tytokine signalmg, the suppressor of (tytokine signals
(SOCS) which work as a negative feedback system to inhibit the Jaks either directly or
non-directly (Nicholson and Hilton 1998). CD40-mediated activation of the Jaks in
monocytes has not been investigated, however in B cells studies have shown that CD40
may associate with Jak3 (Hanissian and Geha 1997). The data thus far indicate that IL4 and IL-10 inhibit the early PTK activity initiated from CD40 ligation suggesting that
EL-4 and IL-10 may induce protein tyrosine phosphatase (FTP) activity, resulting in the
suppression of the CD40 signaling pathway in monocytes, and thus suppression of
ERKl/2 activity.

MAPK Signaling

The mitogen-activated protein kinases (MAPK) family members are a group of
protein serine/threonine kinases that are activated in response to a variety of
extracellular stimuli and regulate a number of cellular responses. Along with other
signaling pathways, the MAPK hunily members mediate signal transduction by
differentially altering the phosphorylation status of transcription factors (Sivaraman and
others 1997; Das and Vonderhaar 1996; Tong and other 1997) (Figure 3). There are
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three members of the MAPK family; extracellular signal regulated kinase (ERKl/2), cJun-N-terminal kinase (JNtQ and p38. The ERKl/2 signaling cascade involves the
activation of receptor tyrosine kinases (which have src homology) which provide the
binding site for the adaptor protein, growth receptor-bound protein 2 (GRB2), which
localizes the guanine nucleotide exchange Actor, son of sevenless (SOS), to the plasma
membrane. SOS activates Ras by exchange of GTP for GDP (Winston and Hunter
1996; Sagata 1997; Takeuchi and others 1999; Hildt and Oess 1999). The Ras-GTP
activated Raf phosphorylates a dual specificiQr kinase MAPK/ERK kinasel/2
(MEKl/2), which is phosphorylated on serine 218 and 222 (Avruch and others 1994).
Active MEKl/2 dually phosphorylates ERKl/2 on theonine 183 and Qrrosine 185
(Burack and Sturgill 1997; Cobb and others 1996). Active ERK translocates to the
nucleus to phosphorylated a variety of transcription factors including Elk-1 (Gille and
others 1992; Cheng and others 1996), C/EBPp (NF-IL-6) (Nakajima and others 1993),
ATF-2 (Abdel-Hafiz and others 1992), and NF-kB (Dadgostar and Cheng 1998).
The INK signaling pathway is activated in several ways including exposure to UV
radiation, heat shock, or inflammatory cytokines (Su and Karin 1996; Hibi and others
1993) and is mediated by Rac and cdc42, two small GTP binding proteins (Davis
1994). Activated cdc42 binds to PAK65 which activates MEK kinase (MEKK-1).
MEKK-1 phosphorylates MEKK-4 at serine 219 and serine 223. The active MEKK-4
phosphorylates JNK which translocates to the nucleus and activates a variety of
transcription factors including c-Jun (Kyriakis and others 1994; Derijard and others
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1995), ATF-2 (Gupta and others 1995) and Elk-1 (Cavigelli and others 1995).
The p38 MAPK Amily member is activated in response to several stimuli including
inflammatory cytokines, endotoxins and osmotic stress (Tong and others 1997; Han and
others 1994; Rouse and others 1994). P38 is activated by MEK kinase kinase-3
(MKK3) a dual specificity kinase. Following phosphorylation p38 translocates to the
nucleus and phosphorylates and activates transcription Actors including ATF-1, CREB
(Tan and others 1996), Elk-1 (Price and others 1996), CHOP (Wang and Ron 1996),
and ATF-2 (Raingeaud and others 1996).
The sites of phophorylation are conserved between the MAPK family
members, however, these sites are located within distinct dual specificity
phosphorylation motifs; TEY for ERK, TPY for JNK, and TGY for p38 (Davis 1994;
Derijard and others 1994; Raingeand and others 1995). Additionally, the MAPK
family members share sequence homology -45% sequence homology between JNK and
ERK (Moriguchi and others 1996), and -50% homology between p38 and ERK (Tong
and others 1997) .
This dissertation represents the results of studies designed to evaluate the role of
CD40 signaling in two key cells found at atherosclerotic lesions, SMC and
monocytes/macrophages, which contribute to the maintenance and/or exacerbation of
vascular inflammation. We investigated the functional activities expressed by SMC in
response to CD40 ligation, and critical components involved in CD40-mediated SMC
chemokine synthesis. Additionally we examined the role of MAPK family members in
CD40-mediated synthesis of inflammatory cytokines and chemokines in
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monocytes/macrophages and SMC. and evaluate the role of anti-inflammatory qrtokines
on CD40-mediated activation of ERKl/2 MAPK family member(s), a critical
component in CD40-mediated induction of mono<yte IL-ip and TNFa synthesis in
monocytes and IL-8 and MCP-1 synthesis in SMC. Gaining a better understanding of
CD40-mediated activation of specific kinases, transcription Actors and inflammatory
cytokines and chemokines, and how these events can be modulated by natural medAtors
will help identify potential targets for drug intervention.
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CHAPTER!
MATERIALS AND METHODS

Control o f endotoxin contamination

All cell culture reagents used were either certified as low endotoxin when
purchased, or were ensured low endotoxin as determined by chromogenic limulus assay
(BioWhittaker, Walkersville, MD). Stock solutions containing > 1 ng/ml (10
endotoxin units/ml) were considered unacceptable. Stock solutions were diluted in
assays such that endotoxin levels did not exceed 1 pg/ml.

Inhibitors/ Reagents

The MEK1/MEK2 inhibitor PD98050 was obtained firom New England BioLabs,
Inc. (Beverly, MA). The p38 MAPK inhibitor SB203580, the PTK inhibitor
Herbimycin A and the PKC inhibitor RO-31-75499 were purchased from Calbiochem
(La Jolla, CA). H7 was purchased from Sigma Chemical Co. (St, Louis, MO). IL-4
and IL-10 were purchased from R&D Systems (Minneapolis, MN). Sodium
orthovanadate (Na^VOJ was acquired from Fisher Scientific, (Fair Lawn, NJ).

Antibodies

The following mAB's were prepared form culture supernatants of hybridomas
purchased form American Type Culture Collection (ATCC, Rockville, MD): IgG

15
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mouse anti-human CD3 (OKT-3), IgG mouse anti-human CD8 (OKT-8), IgG mouse
anti-human monocyte (3C10), IgG mouse anti-human B cell (LYM-1), IgM mouse anti
human NK cell (hNK-1), and IgG mouse anti-human CD40 (G28-5). BioMag* goat
anti-human IgG and IgM was obtained from PerSeptive Diagnostics, Inc. (Cambridge,
MA). FITC-conjugated donkey anti-mouse IgG (H + L) was purchased from Jackson
Immunoresearch Laboratories, Inc. (West Grove, PA). IgG mouse anti-human CD154
mAh was obtained from Genzyme (Cambridge, MA). Rabbit antibodies recognizing
the active, phosphorylated (Thr‘“ , Tyr‘“ ) form of ERKl/2 were acquired from
Promega (Madison, WI) and New England BioLabs. Rabbit antibodies recognizing
phosphorylated p38 (Thr‘“ , Tyr‘“ ) and phosphorylated JNK (Thr^“ , Tjrr*“ ) were
purchased from New England BioLabs. Horseradish peroxidase-conjugated F(ab')2
donkey anti-rabbit AB was purchased form Jackson ImmimoResearch Laboratories
(West Grove, PA). Monoclonal mouse anti-human CD 154 was prepared from culture
supernatant of the hybridoma 5C8 (American Type Culture Collection, Rockville,
MD). The monoclonal mouse IgG anti-human CD40 used for flow cytometry was
prepared from culture supernatant of the hybridoma G28-5 (American Type Culture
Collection, Rockville, MD). The FITC-conjugated donkey anti-mouse IgG (H 4- L)
was purchased from Jackson Immunoresearch Laboratories, Inc. (West Grove, PA).
Cell Lines
Cell lines used in these studies included 293 (human embryonic kidney, ATTC),
stable transfectants of 293 which express high levels of CD154 (Yellin and others
1994), the human T cell leukemia line Jurkat (ATCC) and the CD 154^ subclone of
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Jurkat, D l.l (Yellin and others 1991). Both D l.l and 293-CD154 transfectants were
gifts of Dr. Seth Lederman, ColumbA Universify. Cell lines were maintained in RPMI
1640 (Hyclone, Logan, UT), containing l(X)mM HEPES, SO pg/ml gentamicin, and
5 % fetal bovine serum (FBS) (R-5). The 293-CD154 transfectants (created by co
transfection with pcDNA 1-CD154 and pRSVneo) were periodically passaged in 200
pM G418 (Gibco/BRL). The hiunan aortic smooth muscle cell line (SMC) was
obtained from Clonetics Corporation (San Diego, CA). The SMC line designated
AOSMC 2634-3 by Clonetics, was characterized phenotypically as SMC and found to
be virus-free. The line was maintained in SmGM*-3 BuUetKit* (Clonetics) containing
0.5pg/ml human recombinant Epidermal Growth Factor, 5mg/ml Insulin, 1pg/ml
human recombinant Fibroblast Growth Factor, 50mg/ml Gentamicin, and 2% FBS
(Clonetics Corporation). The SMC cell line was rested in Human Endothelial-SFM*
Gibco/Life Technologies, Grand Island, NY). SMC were cultured in 25cm tissue
culture flasks (Coming, Incorporated, Coming NY).

CD4^ T cell Purification and Activation
CD4^ T cells were purified by negative magnetic panning from elutriation-enriched
T cell populations. Cells were incubated in R-5 with mAB's against cell surface
molecules generated from the hybridomas OKT-8 (anti-CD8^ T cell), 3C10 (anti
monocyte), LYM-1 (anti-B cell), and hNK-1 (anti-NK cell), used as culture
supematants at dilutions of 1:10, for 30 min at RT. Cells were then treated with
BioMag® iron-conjugated antibodies to murine IgG and IgM (PerSeptives Diagnostics,
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Cambridge, MA) for 30 min with gentle shaking at 4°C. Cells were diluted with DPBS
in 75 cm^ flasks (Fisher Scientific) and the CD4 populations were removed via 27
megagauss Oerstead magnets (PerSeptives DAgnostics). A sample of the purified
population was stained with an FITC conjugated anti-CD4 mAh and analyzed by flow
cytometry on a FACSTAR* flow cytometer (Becton Dickinson, San Jose, CA).
Resulting populations were typically found to be greater than 95% CD4 . CD4^ T
cells were then rested in R-5 alone, or activated for 6 h in R-5 by mcubation with
lOng/ml phorbol myristic acetate (PMA) (Sigma) and 0.5pM ionomycm (Calbiochem,
San Diego, CA). Expression of CD 154 on activated, but not restmg, CD4^ T cells was
then confirmed by flow cytometric analysis on a FACSTAR* plus flow cytometer
(Becton Dickinson).

Monocvte Isolation and Culture
Blood was collected from normal, healthy human volunteers and PBMC's were
isolated over a Ficoll densify gradient (Fico-Lite-LymphoH, Atlanta Biologicals,
Norcross, GA). PBMC's were plated at a density of 5 x 10®cells/well in 24-well tissue
culture plates (Falcon Primaria, Lmcoln Park, NJ) in RPMI 1640 (Hyclone,
Logan, UT), containing 100 mM HEPES, 50 pg/ml gentamicin, and 5% FBS (R-5).
Monocytes were isolated by plastic adherence for 1 h at 37 °C after which nonadherent
cells were removed by Pasteur pipetting during 2 washes with Dulbecco's PBS (DPBS).
Cells were maintained in R-5 overnight prior to treatment.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

19
T-Cell Plasma Membrane Preparation
For the preparation of purified plasma membranes, resting and activated purified
CD4^ T cells were resuspended in a hypotonic buffer containing SO mM Tris-HCL, pH
7.4, 25 mM KCl, 5 mM MgClz, and 50 pg/ml phenolmethylsulfonyl fluoride (PMSF)
for 30 min on ice. The cells were then homogenized using a PowerGen 35
homogenizer (Fisher Scientific) until completely disrupted as determined
microscopically. Disrupted cells were centrifuged at 500 x g for 5 min to remove
nuclei, then centrifuged at 95,(X)0 x g for 30 min using a Ti-50 rotor in a Beckman L565 Ultracentrifuge. Cell debris was resuspended in 35% (wt/vol) sucrose/hypotonic
buffer then layered on 73% (wt/vol) sucrose/hypotonic buffer. Hypotonic buffer was
layered on the 35% sucrose and the samples were centrifuged using a SW50.1 rotor at
130,000 Xg for 1 h to separate plasma membranes. The plasma membrane layer (at the
73%-35% interface) was collected and diluted 1:5 with hypotonic buffer, then
centrifuged again for Ih at 130,000 x g to pellet purified plasma membranes. The
membrane pellets were resuspended in PBS and total protein was determined by
microtiter plate protocol of the bicinchoninic acid (BCA) protein assay (Pierce,
Rockford, IL). The BCA protein assay was read on a Biotek Instruments microtiter
plate reader at 561nm.

Flow Cvtometric Analvsis
Smooth muscle cells were harvested from tissue culture flasks with .025%
Trypsin/EDTA (Clonetics Corporation). SMC were labeled with the appropriate
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dilution of the primary antibody 30 min at room tenq>erature, washed in DPBS, and
stained with a FITC-conjugated donkey anti-mouse IgG (H + L) secondary antibody
for 30 min at RT. Cells were washed in DPBS and analyzed for CD40, CD95 or
ICAM surface expression on a FACSTAR* plus flow cytometer (Becton Dickinson, San
Jose, CA).

Electrophoretic Mobility Shift Assay (EMSA)
After treatment or stimulation as required by the particular assay, cells were
collected and lysed to isolate nuclei based on the method of Bturas and others (1994).
Briefly, cells were lysed in hypotonic buffer containing 10 mM KCl, 0.3 M sucrose, 10
mM P glycerol phosphate, 0.2 mM EDTA, 0.4% nonidet P-40, 1 mM PMSF and 1
;fg/ml each of leupeptin and pepstatin, on ice for 30min with gentle agitation.
Following lysis, nuclei were collected by centrifugation at 11,500 x g for 5min.
Nuclear proteins were extracted by incubating nuclei in a buffer containing 25%
glycerol, 0.3 M KCl, 1.5 mM MgCl;, 0.2 mM EDTA, 0.5 mM dithiothreitol, 1 mM
PMSF, and 1 /tg/ml each of leupeptin and pepstatin for 30 min on ice. Extracts were
centrifuged at 11,500 x g and supematants were collected as nuclear extracts. Protein
determinations were performed by the BCA micro protein assay. Extracts were
aliquoted and stored at -80° C. Binding assays were performed using a gelshift assay
kit consensus oligonucleotide containing the binding element for NF-kB (Geneka,
Quebec, Canada) that was end-labeled using ^P-gamma ATP (Amersham Pharmacia
Biotech, Inc., Piscataway, NJ). Nuclear extracts were incubated with gel shift binding

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

21
buffer and

end-labeled oligonucleotide at approximately 5x10® cpm. Binding

reactions were done per Geneka protocol. Following binding reactions, samples were
analyzed on 5% polyacrylamide gels. Following electrophoresis, gels were dried onto
Whatman filter paper and exposed to x-ray film fi-om several hours to overnight at

room temperature. X-ray films were analyzed by scanning densitometry using the UNSCAN-IT-gel automated digitizing system. Silk Scientific Corp., Orem, UT.

Western Blot Analvsis
Prior to stimulation, monocytes were pretreated with 50#tM Na^VO,* for 20 min to
negate FTP effects on tyrosine-phosphorylated cellular proteins during stimulation.
After monocyte or smooth muscle cell treatment/stimulation in 24-well plates, cells
were lysed in 50 /xl boiling treatment buffer (125 mM Tris, pH 6.8, 2% SDS, 20%
glycerol, 1% beta-mercaptoethanol, and 0.003% bromophenol blue) containing 1 mM
each PMSF and sodium orthovanadate. Samples were boiled an additional 5 min prior
to protein separation by SDS-PAGE on 15% minigels. Gels were equilibrated in
transfer buffer (48 mM Tris, pH 9.2, 39 mM glycine, 1.3 mM SDS, and 20%
methanol) for 15 min prior to transfer. Protein transfer to nitrocellulose membranes
(Coming Costar Corp., Kennebunk, ME) was performed at 15V for 30 min using a
Trans-Blot* SD Semi-Dry Electrophoretic Transfer Cell (Bio-Rad, Richmond, CA).
Dried membranes were blocked by gentle agitation in PBS containing 0.1% Tween 20
and 1% BSA (blocking buffer) for 30min at 37° C. Membranes were incubated with
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the relevant primary Ab in blocking buffer for 30 min at 37° C, and then washed for 10
min x 2 washes in PBS containing 0.1% Tween 20 (wash buffer), followed by
incubation with the relevant (HRP-conjugated) secondary Ab for 30 min at 37 °C (if
primary antibody not HRP-conjugated), and then washed for 10 min x3 in wash
buffer. Ab-bound proteins were detected using an ECL™ Western blotting analysis
system (Amersham Corp.. Arlington Heights, IL) and the membranes were exposed to
Kodak X-Omat LS X-ray film (Eastman Kodak, Rochester, NY). X-ray films were
analyzed by scanning densitometry using the UN-SCAN-IT-gel automated digitizing
system.

Analvsis of Chemokine Production
Analysis of IL-8 and MCP-1 production by SMC stimulated through CD40, was
examined by ELISA. SMC were plated in 96 well microtiter plates and rested for 10
days in serum free medium. The cells were then treated with IFNy for 5 days to upregulate CD40 expression. SMC were co-incubated with activated T cell membranes
(TmA), resting T cell membranes (TmR), 293 parent cell line, 293-CD154
transfectants, Jurkat cell line, or D l.l cells. Supematants were harvested after an 18-h
incubation and assayed by enzyme-linked immunosorbant assay (ELISA) using R&D
system’s Quantikine™ human enzyme linked immunosorbant assay system or OptEIA™
sets for human IL-8 and MCP-1, PharMingen (San Diego, CA).
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RNAse Protection Assay
Following stimulation of SMC, cells were lysed and RNA was isolated using TRIzol*
Reagent (Life Technologies/Gibco) per TRIzol* protocol. The Riboquant* Multi-Probe
(PharMingen) RNAse protection assay system was used to detect mRNA species. The
multi-probe was labeled with a-®^P-UTP (Amersham), and hybridized to the RNA.
RNAse treatment and purification of protected probes was performed per Riboquant*
protocol. Samples were analyzed on ()uickPoint™ precast gels (NOVEX, San Diego,
CA), and exposed to Kodak X-Omat LS X-ray film.

Alloreactive Proliferation Assay
A total of 4x10® SMC per well were plated in 96-well tissue culture plated in SMGM*3, and lOOU/ml recombinant human IFNy was added after overnight culture. On day

3, cultured cells were washed with PBS, and treated with SO ^g/ml mitomycin C
(Sigma Chemical Co.) to ensure that they were unable to contribute to the
measurement of [®H]-thymidine incorporation used to assay T cell proliferative
responses. In some experiments, the SMC were fixed, with freshly prepared 0.8%
paraformaldehyde at room temperature (RT) for 10 minutes, rather than mitomycin Ctreated. The cells were washed with PBS prior to addition of 2x10* human CD4^ T
cells per well with or without IL-1 (1% P388D1 supernatant) as a source of costimulus.
Three days after addition of the T cells, the cells were pulsed with 0.5 /iCi/well
[®H]thymidine for 3 h and harvested on glass fiber filters for scintillation counting.
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CHAPTERS
RESULTS

CD40 Signaling in Monocvtes

CD40 Activation of ERKl/2 in Monocvtes
Previous research done in our laboratory demonstrated that CD40-mediated
monocyte inflammatory cytokine synthesis was dependent on activation of PTKs (Poe
and others 1998). To further investigate the activation of PTKs, the role of MAPK
family members in T cell activation of monocytes through CD40 signaling was
evaluated. Stimulus was provided by purified plasma membranes from CD4^ T cells
which had been activated for 6 hours (a time point at which CD 154 expression was
optimal) designated TmA. Purified plasma membranes from resting (CD 154 ) T cells,
designated TmR, were used as a control. Plasma membrane preparations were titrated
for activity based on membrane protein concentrations. In the experiments presented in
this dissertation, membranes were used at lOpg of protein/ml. The ability of TmA to
induce MAPK phosphorylation was evaluated over a 2 hour time period postactivation.
ERKl/2 phosphorylation was evident at 10 minutes, and declined at 2 hours (Figure
4A, top panel). The blot was stripped and reprobed with antibody recognizing both
phosphorylated and nonphosphorylated forms of ERK present demonstrating that the
differences observed were not due to differences in the level of ERKl/2 protein, or
artifacts of gel loading (Figure 4A, bottom panel).
24
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Figure 4. CD40-Mediated Activation of ERKl/2 m Monocytes. A, analysA of ERKl/2
phosphorylation . Monocytes were left unstimulated or stimulated with LPS for 30
minutes, or TmA for 10, 30, 60 or 120 minutes. After stimulation lysates were
harvested and analyzed by western blot using an antibody specific for the
phosphorylated form of ERKl/2 (top panel) or antibodies recognizing total ERKl/2
(bottom panel). B, analysis of p38 and JNK phosphorylation. Monocytes were
stimulated as in A, lysates were harvested and analyzed by western blot using
antibodies specific for the phosphorylated forms of p38 and JNK.
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Although LPS stimulation resulted in the activation of the MAPK family members p38
and JNK, treatment of the monocytes over the same time period examined in 3A did not
induce or enhance p38 or JNK phosphorylation (Figure 4B). These data suggested that
CD40 signaling in monocytes resulted in the phosphorylation of the MAPK Amily
member ERKl/2, but not in the phosphorylation of p38 or JNK over the time period
examined (Suttles and others 1999).

IL-4 and IL-10 Inhibit CD40-Mediated Monocvte ERKl/2 Phosphorvlation
In previous work, IL-4 and IL-10 were found to inhibit CD40-induced activation of
PTK activity and the subsequent synthesis of inflammatory cytokines (Poe and others
1997). Additionally our previous work indicated a role of MEK and ERK activation in
this pathway, therefore we hypothesized that IL-4 and IL-10 acted by interference of
the signaling cascade leading to ERKl/2 activation. To test this hypothesis, monocytes
were pretreated for an 18-h period with IL-4 or IL-10 prior to TmA stimulation and the
cell lysates were assayed for phosphorylation of ERKl/2. ERKl/2 activation was
decreased in a dose-dependent manner with both IL-4 and IL-10 (Figure S).
Quantification by scanning densitometry indicated that a dose of 50 ng/ml IL-4 resulted
in 79% decrease in the level of phosphorylation observed over background in response
to TmA. A 90% decrease was observed with treatment of IL-10 at 50 ng/ml. Neither
of these cytokines affected the level of expression of ERK’s during this time period as
shown by Western blots of the same samples, reprobed with an antibody reactive with

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

27

TmA •!>IL-4

TmA + IL-10

I_______

/ / / / / /
Phospho-ERKI
Pho*pho-ERK2
800
600
ë 400 "5 200 -

Total ERK1
Total ERK2

Figure 5. Effects of IL-4 and IL-10 on CD40-Mediated ERKl/2 Activation in
Monocytes. Monocytes were pretreated with IL-4 or IL-10 at 5, 10, and 50 ng/ml, as
indicated, then left unstimulated (control) or stimulated with TmA for 30 minutes. Cell
lysates were harvested and analyzed by western blot for level of ERKl/2
phosphorylation using anti-phospho-ERKl/2 antibodies (top panel). The film was
scaimed and the digitized image analyzed for band density. The histogram represents
density (total pixels minus background x 10 ^) of the ERK2 bands (middle panel). The
membrane was stripped and reprobed using antibodies recognizing total ERK (bottom
panel).
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total ERKl/2, which show equivalent levels of ERKl/2 regardless o f treatment (Fig
5,bottom panel).

Evidence of T Cell-SMC Interactions

SMC Express CD40
Monocytes can interact with activated CD4^ T cell through several receptorrligand
pairs including the interaction of CD40 on monocytes with its natural ligand CD 154
present on activated CD4^ T-cells. This interaction results in the up-regulation of proinflammatory cytokine synthesis. Both monocytes and SMC appear to play a role in
vascular inflammation by interacting with T cells. We next examined SMC for CD40
and other receptors which have the ability to interact with T cells similar to monocytezT
cell interactions. Using the monocytezT cell model we hypothesized that vascular
smooth muscle cells may interact in a similar way contributing to the development of
vascular inflammation. To address the hypothesis we phenotyped the SMC to
determine the expression of the cell surface molecule CD40. SMC were treated over a
period of 0 to 5 days with Thl cytokine IFN-y, which is a costimulus for macrophage
activation and has been shown to up-regulate MHC-II expression in other cell lines.
Cells were harvested and stained with anti-CD40 antibodies and analyzed by flow
cytometry for CD40 expression (Figure 6). Untreated cells were negative for CD40
expression. However, IFNy treatment induced CD40 expression which increased over
the five day period. The experiment was carried out through day 7
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Figure 6. IFNy Up-regulates CD40 Expression on SMC. A, CD40 surface expression
on SMC. SMCs were left untreated or treated with lOOU/ml of IFNy for 3 days. Cells
were harvested and stained for CD40 surface expression. Cells were analyzed by flow
cytometric analysis. B, Kinetics of IFNy treated on CD40 surface expression on SMC.
SMC were left untreated or treated with IFNy over time period of 1 to 5 days. Cells
were harvested and analyzed by flow cytometric analysis.
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(data not shown), however, expression declined consistently after day 5.

SMC Express CD95
Monocytes can interact with activated T ceils through several receptorrligand pairs
in addition to the CD40:CD1S4 interaction. Monocytes express CD95 (Fas), a
member of the TNF receptor superAmily. CD95 binds to its ligand CD95L (Fas
ligand) expressed on T cells. This interaction can lead to programed cell death or
apoptosis. Apoptosis of SMC has been demonstrated in vivo and in vitro (Bennett and
others 1995). Apoptosis of SMC observed in atheroma suggest that this process
contributes to vascular remodeling that results in intimai thickening and fibrous cap
formation. We hypothesized that SMC express CD95, which could interact with T cells
through the CD95:CD95L receptorrligand interaction similar to the monocyte-T cell
model, resulting in apoptosis, and vascular remodeling. To address this hypothesis,
SMC were analyzed for CD95 expression by flow cytometry (Figure 7).

SMC Present Antigen to CD4^ T cells
Monocytes have the abiliQr to display peptide-MHC complexes in a form that can be
recognized by T cells, and are known as classical antigen presenting cells (APC). The
interaction of T cells with monocytes through antigen presentation results in reciprocal
activation involving both contact-dependent and cytokine-mediated signals.
Since the possible SMC-T cell interactions seem to resemble the monocyte-T cell
model, we were interested in exploring the possibiliQr of antigen presentation by SMC
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Figure 7. SMC Express CD95. Analysis of cell surface expression of CD95(Fas) on
SMC. SMC were left untreated or treated with IFNy for 5 days. After 5 days of
treatment the cells were were harvested, stained for sur&ce CD95, and analyzed by
flow cytometric analysis.
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to T cells. Previous work done in the murine system has shown that pure populations
of vascular smooth muscle cells (VSMC) clones are capable of antigen processing and
presentation via the exogenous pathway to syngeneic or histocompatibili^ matched
CD4^ T cells. We have hypothesized that human SMC are also capable of antigen
presentation to allogeneic CD4^ T cells. To determine this human SMC were treated
with lOOU/ml IFN-y for 3 days, which had been shown in previous experiments to
optimally induce expression of class H MHC in monocytes. SMC were IFN-y primed
for three days, washed with DPBS and treated with mitomycin C to ensure that the cells
were unable to contribute to the measurement of [^H]-thymidine incorporation or fixed
with 0.8% paraformaldehyde. The SMC were co-cultured with human allogeneic
CD4^T cells in the presence or absence of IL-ip as a source of co-stimulus. On day 3
of culture, wells were pulsed with [^H]-thymidine, and SMC were evaluated for their
ability to activate the T cells by allo-antigen presentation. CD4^T cells incubated in the
presence of fixed allogeneic SMC proliferated excessively as compared to the
mitomycin C treated group (Figure 8). These data indicate that the SMC are capable of
allo-antigen presentation to CD4^ T cells, and therefore reciprocal activation.

Influence of CD40 Signaling on SMC Chemokine Production
Our laboratory has demonstrated that CD40 signaling in monocytes results in the
activation of inflammatory cytokine synthesis and rescue from apoptosis. We have also
demonstrated that both of these events are critically dependent on the activation of PTK
and but does not exhibit dependence on the activi^ of the PKC family (Poe and others
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Figure 8. Alio-Antigen Presentation to CD4^ T Cells by SMC. SMC were plated in
96-well culture plates, IFNy treated, and either paraformaldehyde fixed or treated with
mitomycin C. 10* allogeneic CD4^ T were added to the SMC cultures in the presence
or absence of IL-ip (1%P388D1 supernatant). On the third day T cell proliferation
was assayed by [*H]thymidine incorporation. The average cpm [*H]thymidine
incorporation ± standard deviation of triplicate samples.
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1997) However, the activi^ of PTK and the activity of the serine/threonine PKC
family has been demonstrated in CD40 signaling in B cells. We were interested in
determining the nature of kinase involvement in CD40 signaling in SMC. CD40mediated IL-8 and MCP-1 production were evaluated in SMC pretreated with inhibitors
of PTK and PKC activiQr. SMC were treated either with herbimycin A, a potent, broad
PTK inhibitor, or H-7, an inhibitor of PKC, prior to CD40 stimulation. The inhibitors
were used at concentrations based on previous experiments (Suttles and others 1996),
and caution was exercised to ensure that the concentrations used did not affect cell
viabiliQr and total protein synthesis. Stimulus was provided by plasma membranes

purified from CD4^ T cells which had been activated for 6 hours (a time point at which
CD 154 expression was optimal) as well as by co-culture of SMC with CD 154
transfectants, or the CD 154^ Jurkat T cell variant, D l.l (Yellin and others 1991;
Yellin and others 1994). SMC were pretreated with or without 0.5 pg/ml HerbA and
2 pg/ml H-7 for -18 hours and then stimulated through CD40 with plasma membranes
from either activated (CD 154^ ) CD4^ T cells designated TmA or CD 154-transfected
293 cells. Supematants were collected for analysis at 18 hours. Controls consisted of
supematants from SMC stimulated with resting (CD 154 ) CD4^ T cells designated
TmR or the 293 parent cell line. SMC EL-8 and MCP-1 synthesis was
induced by co-culture with TmA and the CD 154 transfectants, but not by co-culture
with TmR or the control 293 population. Furthermore both IL-8 and MCP-1
production was suppressed by both HerbA and H-7 which suggests that both PTK and
PKC activity is required for CD40-mediated activation of SMC IL-8 and MCP-1
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production (Figure 9). Additionally, we demonstrated that activation o f SMC induced
by co-incubation with CD154 transfectants is inhibited by the addition of anti-CD 154
antibodies confirming that the primary activating component o f this interaction is the
CD40 ligand, CD154 (Figure 10). These data suggest that CD40-mediated IL-8 and
MCP-1 synthesis in SMC is a CD40-mediated event and dependent on both PTK and
PKC activity.

CD40 Signaling in SMC results in Cvtokine and Chemokine mRNA Svnthesis
SMC have the capacity to play an active role in vascular inflammation by their
ability to produce a variety of cytokines including IL-1, TNF-a, IL-6, GM-CSF, IL-8,
MCP-1, and monocyte chemotatic and activation factor (MCAF) (Ross 1993). The
production of these cytokines by SMC may contribute to the recruitment and activation
of leukocyte populations, resulting in vascular inflammation and plaque formation.
Since we observed that CD40 signaling in SMC resulted in the induction of the
inflammatory chemokine synthesis, we next addressed the question how specific is
CD40-mediated chemokine and cytokine synthesis in SMC. To address this question
SMC were stimulated with TmA for various time points, and the mRNA was extracted
and evaluated for a panel of inflammatory cytokines and chemokines by an RNAse
protection assay as described in materials and methods. We previously observed that
PTK, PKC, MEK/ERK and p38 were involved in CD40-mediated induction of IL-8 and
MCP-1 in SMC, therefore we hypothesized that activation of these kinases had an effect
on CD40-mediated cytokine/chemokine mRNA synthesis. To determine the
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Figure 9. Requirement for PTK and PKC Activity in CD40-Mediated SMC IL-8
and MCP-1 Synthesis. SMC were pretreated with the PTK inhibitor, HerbA
(0.5^g/ml) or the PKC inhibitor H-7 (2^g/ml) for 18 hours. SMC were either
stimulated with 293-CD154 cells or the control parent 293 cell line. After 18 hours
stimulation, supematants were removed and analyzed by ELISA.
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Figure 10. IL-8 Production by SMC is a CD40-Mediated Event. SMC were left
unstimulated (control) or stimulated for 18 hours with 293 parent cell, CD 154
transfectants, or CD 154 transfectants + antibody, as indicated. Supernatants were
assayed for lL-8 production by ELISA.
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involvement of PTK, PKC, ERKl/2 and p38 activiQr in CEMO-mediated induction of
cytokine/chemokine mRNA synthesis, SMC were pretreated with or without the PTK
inhibitor. HerbA, the PKC inhibitor H-7, the MEK/ERK inhibitor PD98059, and the
p38 inhibitor SB203S80, and stimulated at several time points with TmA (figure 11).
Synthesis of TG Pp-l, lL-8 and IL-IRA was observed with SMC stimulated with TmA.
Inhibition of the cytokines/chemokines was seen with PD98059, SB203580 and HerbA
treatment, but not with H-7. These data indicate that CD40 signaling in SMC results in
the induction of cytokine/chemokine mRNA synthesis, and that activation of the
MEK/ERK, p38 and possibly other pathways are involved.

CD40 Activation of ERKl/2 and p38 in SMC
Previous studies firom our laboratory demonstrated that CD40 signaling in
monocytes is dependent on the activation of the ERKl/2 MAPK family members
(Suttles and others 1999). In contrast, in B cells previous research has shown that
CD40 signaling involves activation of the MAPK family members INK, p38 and

ERKl/2 (Swantek and others 1997; Sanghera and others 1996). We next addressed the
question are the MAPK signaling pathway(s) activated in response to CD40 ligation in
SMC. All three MAPK family members; ERKl/2, p38 and INK were considered as
candidates. To evaluate the ability of CD40 stimulation to activate the MAPK family
members, SMC were treated with TmA or TmR over a 2 hour time period post
activation. After a 10 to 120 minute incubation period, cell lysates were harvested and
analyzed for MAPK activation by Western blot using antibodies specific for the
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Figure 11. CD40 Activation of Cytokine/Chemokine mRNA. SMC were left
unstimulated or stimulated with TmA for 3, 6, or 19 hours in the absence or presence
of 30mM PD98059, 30mM SB203S80, 0.5mg/ml HerbA, or 2mg/ml H-7. Lanel,
unstimulated; lane2, TmA 3hour; lane 3, TmA 6 hour; lane 4, TmA 19 hours; lane 5, 3
hour TmA + HerbA; lane 6, 6 hour TmA + HerbA; lane 7, 6 hour TmA + H-7; lane
8, 6 hour TmA + PD98059; lane 9, 6 hour TmA 4- SB203S80.
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phosphorylated (active) fonns of ERKl/2, p38, and JNK. ERKl/2 and p38
phosphorylation was evident at 10 minutes and declined at 2 hours (Figure 12A and B).
Treatment of SMC with TmA over the same 2 hour time period examined did not
induce JNK phosphorylation (Figure 12C). Probing the blot with antibody recognizing
the nonphosphorylated forms of JNK present revealed that the absence of
phosphorylated JNK present was not due to artiActs of gel loading (data not shown).
Lysates from UV-treated 293 cells (New England Biolabs) were used as a positive
control for anti-phospho-JNK reactive proteins.

CD40-Mediated lL-8 and MCP-1 Svnthesis in SMC is Dependent Upon ERKl/2 and
p38 MAPK Activitv
Since both ERKl/2 and p38 MAPK family members appear to be involved in CD40
signaling in SMC we next wanted to determine if the activation of ERKl/2 and p38
MAPKs have a functional significance in CD40-mediated induction of lL-8 and MCP-1
synthesis. The role of CD40-mediated activation of ERKl/2 and p38 in the induction
of inflammatory chemokine synthesis was explored via upstream blockade of the
ERKl/2 and p38 pathways. Activation of ERKl/2 is catalyzed by M EKl/2, which,
itself, is activated through serine phosphorylation catalyzed by Raf family kinases
(Davis 1993). Use of a specific MEKl/2 inhibitor, PD98059, which prevents Rafmediated activation of MEKl/2 (Allessi and others 1995), (Figure 3), allowed us to
evaluate the role of the MEK/ERK pathway in CD40-mediated induction of SMC lL-8
and MCP-1 synthesis. Additionally, use of a specific p38 inhibitor, SB203580, (Figure
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Figure 12. CD40-Mediated Activation of ERKl/2 and p38 MAPK Family Members in
SMC. SMC were either left unstimulated (control) or stimulated with LPS for 30
minutes, or TmA for 10, 30, 60 or 120 minutes as indicated. Cell lysates were then
harvested and analyzed by Western Blot with antibodies recognizing the phosphorylated
form of A, ERKl/2; B, p38; and C, JNK.
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3), allowed us to evaluate the role of the p38 signaling pathway in CD40-mediated
induction of SMC IL-8 and MCP-1. The influence of PD98059 and SB203S80 on
CD40-mediated SMC lL-8 and MCP-1 synthesis was analyzed by enzyme-linked
immunosorbant assay of SMC supemantants. SMC were stimulated for 18 hours by
CD 154-transfected 293 cells (293-CD154) in the presence or absence of PD98059 and
SB203580. Supernatants were then collected for analysis. Controls consisted of
supernatants from SMC stimulated with the 293 parent cell line. SMC lL-8 and MCP-1
synthesis was induced in response to stimulation with the 293-CD154 cells, but not with
the control 293 parent line. Additionally IL-8 and MCP-1 synthesis was suppressed by
the addition of PD98059 and SB203580 (Figure 13A and B), and had no adverse efrects
on cell viabiliQr in a concentration range of l-lOOpM tested. These data suggest that
MEK activation of ERKl/2 and the activation of p38 are critical elements
in the signaling pathways of CD40-mediated induction of SMC lL-8 and MCP-1
synthesis.

CD40 Signaling in SMC Results in Activation of the Transcription Factor NF-kB
The transcription factor NF-kB is in part critical for gene expression of many
cellular products involved in inflammatory responses, such as TNF-a, IL -ip, lL-6, IL8 and MCP-1 (Sharma and others 1998). Previous observations have shown that
CD40-mediated lL-8 and MCP-1 require activation of ERKl/2 and p38, we
hypothesized that CD40 signaling in SMC results in activation of NF-kB and that
activation of both ERKl/2 and p38 is required. To determine the role of CD40

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

43

Control

+10nM PD98059
+10pM SB203580
1500

3000

4500

Pfcograms/mi IL-8

B
Control
TmA
+10nM PD98059
+10^M SB203580
0

500

1000

1500

Picograms/ml MCP-1
Figure 13. Requirement for ERKl/2 and p38 Activity in CD40-Mediated SMC IL-8
and MCP-1 Synthesis. SMC were left untreated (control) or stimulated with TmA in
the presence or absence of the MEK/ERK inhibitor PD980S9 or the p38 inhibitor
SB203S80. After 18 hours supernatants were harvested and analyzed by ELISA for: A,
IL-8 production or B, MCP-1 production.
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signaling in the activation o f transcription factors contributing to inflammatory cytokine
and chemokine synthesis in SMC, nuclear localization of NF-kB was evaluated by
electrophoretic mobilier shift assay (EMSA) as described in materials and methods.
Additionally, the involvement of the MAPK family members ERKl/2 and p38 in
CD40-mediated activation of NF-kB was examined. SMC were pretreated with or
without the MEK/ERK inhibitor PD980S9 and the p38 inhibitor, SB203S80, and
stimulated with TmA for 30 minutes. NF-kB was activated in SMC cells stimulated
with TmA, and the amount of activation was decreased in cells pretreated with
PD98059 and SB203580 (figure 14). These data suggest that CD40 signaling in SMC
results in the activation and/or nuclear localization of the transcription factor NF-kB,
and that the activation of the MEK/ERK and p38 pathways are critical.
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Figurel. CD40-Mediated Activation of NF-kB in SMC. SMC were left unstimulated
(control) or stimulated with Img/ml TmA for 30 minutes in the absence or presence of
30mM SB203580 or PD98059. Cells were then lysed and nuclear proteins extracted
and an EMSA was performed for NF-kB activation. Band densities were determined
by scanning densitometry. Lanel, unstimulated,; lane 2, Tm; lane 3, TmA +
SB203580; lane 4, TmA + PD98059; lane 5, cold competition assay of 30 minute
TmA stimulation; lane 6, positive control; lane 7, mutant oligo.
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CHAPTER 4
DISCUSSION

The interaction of CD40 with its natural ligand CD 154 contributes to normal cellmediated responses as well as to chronic inflammatory diseases (Stout and Suttles
1996). Atherosclerosis, or vascular inflammation is characterized by the migration of

immune cells (i.e. monocytes, T cells) to the site of injury, which transmigrate through
the endothelium from the media to the intima of an artery. There are many cells which
contribute to the development of the disease, however the presence of activated,
CD 154^ T cells at these atherosclerotic lesions may play a crucial role in the
maintenance and/or exacerbation of inflammation. There are several known functional
attributes acquired in response to CD40 ligation in monocytes/macrophages including
the up-regulation of inflammatory mediators, and the increase of monocyte/macrophage
longevity, both events contributing to the maintenance and/or exacerbation of
inflammatory disease. Studies of tissue sections of atherosclerotic plaques have found

the accumulation of activated (CD154^), CD4^ T lymphocytes (Mach and others 1997)
which have the capacity to interact with CD40 expressing cells in the vasculature
including endothelial, monocytes/macrophages, and smooth muscle cells. Previous
research has shown that both monocytes/macrophages and SMC have the ability to
contribute to vascular inflammation by the production of inflammatory
cytokines/chemokines, tissue factor, the up-regulation of adhesion molecules, and both

46
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have the propensi^ to become lipid-laden foam cells (Poe and others 1997; Mach and
others 1997), In vascular inflammation the role of CD40, and the interactions that occur
between major cell Qrpes contributing the formation of atherosclerotic plaques is
currently under investigation. Experiments described in this dissertation were
performed to determine the role of CD40 signaling in monocytes and SMC in the
development of atherosclerosis. We examined the functional attributes acquired by
SMC in response to CD40 ligation, and the role of MAPK signaling pathways activated
in response to CD40 signaling in both monocytes and SMC.
Previous research done in our laboratory investigated the signaling pathways
activated in response to CD40 ligation in monocytes resulting in the production of
inflammatory cytokine synthesis. These studies revealed that the activation of PTK is a
critical component in CD40-mediated activation of monocyte inflammatory cytokine
synthesis, as well as rescue from apoptosis (Poe and others 1998). We evaluated the
role of the MAPK family members as potential downstream mediators of CD40
signaling in monocytes and SMC. MAPK ftunily members ERKl/2, p38 and JNK were

all considered as likely candidates since previous reports have demonstrated that all
three members are activated in response to CD40 signaling in B cells, and in LPS
activation of monocytes (Li and others 1996; Sakata and others 1995; Sanghera and
others 1996). The experiments presented in this dissertation employed primary human
monocytes and primary aortic smooth muscle cells (of less than passage 6). Stimulus
used in these studies included plasma membranes purified from activated (CD 154^)
CD4^ T cells and CD 154 transfectants.
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We observed CD40 signaling in monocytes resulted in the rapid phosphorylation
and activation of the MAPK ftunily member, ERKl/2, however over the same time
period of stimulation, phosphorylation of p38 and JNK was not increased above
background (Figure 4). Additionally, CD40-mediated activation of ERKl/2 in
monocytes was accompanied by enhanced kinase activi^ and is a critical event in
CD40-mediated monocyte IL-ip and TNFd synthesis (Suttles and others 1999). How
ERKl/2 contributes to the transcriptional control of CD40-mediated induction of
inflammatory cytokine synthesis is currently being investigated. Both IL-ip and TNFa
genes are, in part, regulated by several transcription factors including NF-tcB and NFIL-6. NF-IL-6 is a direct substrate of ERKl/2 catalytic activity.
The intent of our research is not only to determine how CD40 signaling in
monocytes results in the activation of inflammatory cytokine synthesis, thus leading to
inflammatory diseases such as vascular inflammation, rheumatoid arthritis, multiple
sclerosis, and inflammatory bowel disease, but also in how to suppress the
inflammatory process. Previous studies suggested that the anti-inflammatory cytokines
IL-4 and IL-10 inhibited CD40-induced monocyte PTK activity, and CD40-mediated
monocyte IL-ip production and together worked in a synergistic manner. Additionally,
inhibition of CD40-mediated IL-ip synthesis, and activation of ERKl/2 in monocytes
was observed in response to pretreatment with an PTK inhibitor suggesting that PTKs
were a critical element in the monocyte CD40 signaling pathway (Poe and others
1997). IL-4 and IL-10 were evaluated for their ability to suppress CD40-mediated
activation of ERKl/2 in monocytes. Both IL-4 and IL-10 modulated CD40-mediated
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ERKl/2 phosphorylation in monocytes, suggesting that the MAPK, ERKl/2 may be
their target of inhibition (Figure S). Both IL-4 and IL-10 signal through receptors
which associate with and activate Jaks upon ligation (O’Shea 1997; Leonard and
O’Shea 1998). The Jaks in turn, activate the Stats which induce negative regulators of
cytokine signaling SOCS, which work as a negative feedback system to inhibit the Jaks
either directly or non-directly (Darnell 1997; Nicholson and Hilton 1998). IL-4 and IL10 appear to act early in the signaling cascade since they inhibit PTK activity in CD40mediated activation of monocyte inflammatory cytokine synthesis (Poe and others
1998). These data suggest that IL-4 and IL-10 may induce tyrosine phosphatase
activity, resulting in the suppression of the CD40 signaling pathway in monocytes, and
thus suppression of ERKl/2 activity.
Recent reports have shown that vascular inflammation involves the participation of
immune competent cells and the activation of inflammatory pathways and mediators.
Both monocytes and SMC are present at atherosclerotic plaques and may be the major
progenitors of vascular inflammation (Mach and others 1997). We observed that SMC
express CD40 (Figure 6) and other receptors that interact with T cells, similar to the
monocytes including cell surftice expression of CD95 (Figure 7), intercellular adhesion
molecule (ICAM), the costimulatory molecules B7-1(CD80) and B7-2 (CD86) (data not
shown), and both have the ability to present antigen to CD4^ T cells (Suttles and others
1994). These data suggest that CD40 signaling in SMC results in the activation of
signaling pathways and induction of inflammatory mediators in a manner similar to
what occurs in monocytes.
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The induction of chemokine synthesis may play an crucial role in the pathogenesis of
atherosclerosis by promoting directed migration of immune competent cells to the site
of injury. The observation that CD40 ligation in SMC induced the inflammatory
chemokines MCP-1 and IL-8 suggested that SMC may play a critical role in the
pathogenesis of atherosclerosis by enhancing the migration of immune competent cells
to the atherosclerotic plaque. We further confirmed that the production MCP-1 and IL8 was a CD40-mediated event by employing anti-CD 154 antibodies and blocking the
synthesis of the chemokines as compared to treatment with an isotype control antibody
(Figure 10). Furthermore, we observed that CD40-mediated induction of MCP-1 and
IL-8 synthesis was partially dependent on both PTK and PKC activity (Figure 9),
suggesting that the CD40 signaling pathway in SMC may also have similarities to the
signaling pathway(s) activated in B cells in response to CD40 ligation. MCP-1 induces
tissue factor (TF), a transmembrane glycoprotein that initiates coagulation, mRNA
synthesis in SMC (Schecter and others 1997). The exposure of TF during plaque
rupture may induce acute thrombosis resulting in myocardial infarction. Further
investigation of MCP-1 production and its effects on SMC may lead to a greater
understanding of the pathways involved and provide important targest for inhibition of
vascular inflanunation and plaque thrombosis. The observation that CD40mediated IL-8 and MCP-1 synthesis was, in part, dependent on PKC activity suggests
that the PKC signaling pathway may play an important role in contributing to vascular
inflammation and may be a potential target for modulation.
We observed that CD40 signaling in SMC resulted in the phosphorylation of the
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MAPK family members ERKl/2 and p38, however we did not see activation of JNK
over the time course examined (Figure 12). The critical dependence of both ERKl/2
and p38 activation on CD40-mediated EL-8 and MCP-1 were also important
observations (Figure 13), suggesting that both pathways may contribute to the
regulation of transcription factor activation resulting in the synthesis of these
chemokines. These data suggMt that CD40-mediated activation of SMC chemokine
synthesis implements a distinctly different signaling pathway from that in monocytes
and B cells. The ability of the MEKl/2 inhibitor PD98059 and the p38 inhibitor
SB203580 to inhibit CD40-mediated SMC chemokine synthesis suggests that both
MAPK signaling pathways are involved in the downstream activation of transcription
factors resulting in chemokine production. Both IL-8 and MCP-1 are in regulated by
several transcription factors including NF-kB (Roebuck and others 1999). SMC
stimulated with TmA resulted in the activation of the transcription factor NF-kB
(Figure 14). Additionally we observed that inhibitors of the MEK/ERK and the p38
signaling pathways suppressed activation of NF-kB suggesting that both of the MAPKs
are involved in CD40-mediated activation of this transcription factor. Activation of
NF-kB in collaboration with the transcription Actors NF-IL-6 (C/EBP) and AP I
regulate both IL-8 and MCP-1 transcription in most cells (Sharma and others 1998).
These data suggest that the CD40 signaling in SMC results in the activation of the
MEK/ERK and p38 MAPK signaling pathways which in turn activate transcription
factors leading to the synthesis of the chemotactic factors IL-8 and MCP-1 at
atherosclerotic lesions. We have demonstrated that CD40-mediated induction of VSMC
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chemokine synthesis was in part regulated by PTK and PKC (Figure 9), this suggests
that both of these pathways may be involved in activation of the MAPK pathways.
Activation of PTK results in activation of ERKl/2, and activation of PKC may result in
the activation of the MAPK p38.
Finally, these data suggest that monocytes/macrophages and SMC present at
atherosclerotic lesions may be critical regulators of vascular inflammation. Both of
these cells are capable of interacting with activated T cells through CD40:CD154
receptor-ligand pair resulting in the synthesis of inflammatory mediators.
Accumulation of activated T cells and monocytes/macrophages at plaque formation sites
and in the neointima, and the activation and proliferation of SMC contribute to the
inflammatory reaction that takes place inside the plaques. The production of
inflammatory cytokines including IL-ip and TNFa, and the secretion of chemotactic
factors including IL-8 and MCP-1 facilitate aberrant migration of immune competent
cells to that site. The delineation of the signaling pathways activated in response to
CD40 signaling in monocytes and SMC will help us to gain a better understanding of
the pathways activated resulting in the onset of inflammation, and will help us define
targets of therapeutic intervention.
The ability of the Th2 cytokines IL-4 and IL-10 to abrogate CD40-mediated
monocyte cytokine synthesis, and ERKl/2 phosphorylation suggests that there may be
direct interaction between the Jak/Stat and ERKl/2 signaling pathways. However,
significantly different to the observations in the monocyte system, neither IL-4 nor IL10 suppress CD40-mediated SMC chemokine production or MAPK phosphorylation
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(data not shown).
Monocytes and SMC exhibit many similar characteristics, but are distinctly
unique in signaling pathways implemented in response to CD40 ligation (Figure 15).
CD40 signaling in monocytes results in the activation of the inflammatory cytokines ILip and TNFa, which are both critically dependent on the activation of the MEK/ERK
pathway, and can be suppressed by the anti-inflammatory cytokines IL-4 and IL-10.
CD40 signaling in SMC results in the synthesis of the chemotactic Actors IL-8 and
MCP-1, which are both dependent on the activation of the MEK/ERK and p38
pathways suggesting divergence in the signaling pathway. However, CD40 signaling in
both monocytes and SMC may result in the activation of divergent signaling pathways
but with the downstream outcome being the activation of transcription Actors which
contribute to the production of inflammatory cytokines and chemokines.
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Figure 15. Summary of CD40-Mediated Signaling Events in Monocytes and SMC
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